Skip to main content

Diagnostic options ยท UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00โ€“50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 436โ€“450 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-4678
CEP290 Gene Sequencing (Joubert Syndrome Type 5) Test

This test identifies pathogenic variants in the CEP290 gene, confirming a molecular diagnosis for Joubert syndrome type 5.

Peripheral Whole Blood, FTA Card, or Extracted DNA 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CEP290 gene"]
Parameters
[]
Preparation
["Provide a complete three-generation pedigree chart", "Provide a neurological examination summary", "Consult physician regarding anticoagulant therapy"]
Indications
["Suspected Joubert syndrome type 5", "Family cascade testing"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 79016-0 ICD-10: Q04.3
Clinical summary
This test identifies pathogenic variants in the CEP290 gene, confirming a molecular diagnosis for Joubert syndrome type 5.
TEST-4654
CEP41 Gene Joubert Syndrome Type 15 Genetic Test

This test identifies pathogenic variants in the CEP41 gene associated with Joubert syndrome type 15.

Whole blood (EDTA) or FTA card 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CEP41 gene"]
Parameters
[]
Preparation
["No special preparation required", "Pre-test genetic counselling recommended"]
Indications
["Symptomatic patients suspected of Joubert syndrome type 15", "At-risk families", "Researchers"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81315-1 ICD-10: Q04.3
Clinical summary
This test identifies pathogenic variants in the CEP41 gene associated with Joubert syndrome type 15.
TEST-2532
CEP57 Gene Analysis for Mosaic Variegated Aneuploidy Syndrome Type 2 (MVA2) Test

This diagnostic test evaluates the CEP57 gene for pathogenic variants associated with Mosaic Variegated Aneuploidy Syndrome Type 2 (MVA2).

Peripheral Whole Blood (EDTA), Extracted Genomic DNA, or FTA Card Blood Spot 21โ€“28 Days (3โ€“4 Weeks) 2,800.00 AED
View
View test specifications and preparation
What it measures
["CEP57 gene variants (SNVs, indels)", "Constitutional mosaic aneuploidies"]
Parameters
[]
Preparation
["No fasting required", "Detailed clinical history required", "Genetic counselling session for pedigree construction mandatory"]
Indications
["Children presenting with dysmorphic features", "Growth delay", "Family history suggestive of aneuploidy syndromes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94473-2 ICD-10: Q99.8
Clinical summary
This diagnostic test evaluates the CEP57 gene for pathogenic variants associated with Mosaic Variegated Aneuploidy Syndrome Type 2 (MVA2).
TEST-2540
CEP63 Gene Microcephaly Genetic Test

This test evaluates the CEP63 gene for pathogenic variants associated with primary microcephaly and Seckel syndrome.

Whole Blood (2-3 mL) or Buccal Swab / FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CEP63 gene", "Single nucleotide variants", "Small deletions", "Copy number changes"]
Parameters
[]
Preparation
["No special preparation required", "Do not discontinue prescribed medication without consulting a doctor"]
Indications
["Suspected autosomal recessive primary microcephaly", "Suspected Seckel syndrome", "Clinical evaluation for developmental delay or intellectual disability"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55232-0 ICD-10: Q02, Q87.1
Clinical summary
This test evaluates the CEP63 gene for pathogenic variants associated with primary microcephaly and Seckel syndrome.
TEST-2349
CEP63 Gene Seckel Syndrome Type 6 Genetic Test

This test identifies pathogenic variants in the CEP63 gene associated with Seckel syndrome type 6.

Whole Blood (EDTA tube), previously extracted DNA, or dried blood spot on FTA card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CEP63 gene variants", "Single-nucleotide variants", "Small insertions/deletions"]
Parameters
[]
Preparation
["Pre-test genetic counselling is mandatory."]
Indications
["Suspected Seckel syndrome type 6", "Confirmation of clinical diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81261-6 ICD-10: Q87.1
Clinical summary
This test identifies pathogenic variants in the CEP63 gene associated with Seckel syndrome type 6.
TEST-5550
CERS1 Gene Progressive Myoclonus Epilepsy Type 8 Genetic Test

This test detects pathogenic mutations in the CERS1 gene associated with Progressive Myoclonus Epilepsy Type 8.

Whole blood (2โ€“5 ml in EDTA tube) or FTA card 3 โ€“ 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CERS1 gene"]
Parameters
[]
Preparation
["No fasting required", "No medication adjustments needed", "Pre-test genetic counseling is mandatory"]
Indications
["Suspected diagnosis of Progressive Myoclonus Epilepsy Type 8", "Family history of PME8", "Need for genetic confirmation for treatment planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 53832-6 ICD-10: G40.3
Clinical summary
This test detects pathogenic mutations in the CERS1 gene associated with Progressive Myoclonus Epilepsy Type 8.
TEST-4975
CERS3 Gene Sequencing for Autosomal Recessive Congenital Ichthyosis Type 9 (ARCI9) Test

This test identifies mutations in the CERS3 gene to confirm a diagnosis of autosomal recessive congenital ichthyosis type 9 (ARCI9).

Peripheral whole blood (EDTA tube), FTA card, or extracted DNA sample 3 โ€“ 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CERS3 gene mutations", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number variants"]
Parameters
[]
Preparation
["Resolve any active infections before sample collection.", "Obtain physician clearance if taking anticoagulant therapy."]
Indications
["Diagnostic confirmation of ARCI9", "Carrier screening", "Family risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48018-6 ICD-10: Q80.8
Clinical summary
This test identifies mutations in the CERS3 gene to confirm a diagnosis of autosomal recessive congenital ichthyosis type 9 (ARCI9).
TEST-6225
CETP Gene High-Density Lipoprotein Cholesterol Level QTL 10 Genetic Test

This genetic test evaluates inherited variants in the CETP gene that influence HDL cholesterol metabolism and cardiovascular risk.

Peripheral whole blood 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CETP gene variants", "HDL cholesterol metabolism predisposition"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Assessment of inherited cardiovascular risk", "Investigation of persistently low or high HDL levels", "Personalized prevention and treatment strategies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94534-3 ICD-10: E78.6
Clinical summary
This genetic test evaluates inherited variants in the CETP gene that influence HDL cholesterol metabolism and cardiovascular risk.
TEST-2785
CFAP53 Gene Heterotaxy, Visceral Type 6 Genetic Test

This test identifies pathogenic variants in the CFAP53 gene associated with heterotaxy syndrome.

Whole blood (EDTA) 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CFAP53 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Neonates and children with suspected heterotaxy syndrome", "Individuals with complex congenital heart defects", "Family history suggestive of CFAP53-related heterotaxy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: Q89.3
Clinical summary
This test identifies pathogenic variants in the CFAP53 gene associated with heterotaxy syndrome.
TEST-3781
CFB Gene Hemolytic Uremic Syndrome (aHUS) Genetic Test

This test identifies pathogenic variants within the CFB gene, a key factor in the development of atypical Hemolytic Uremic Syndrome (aHUS). It provides a definitive molecular diagn...

Whole Blood (EDTA) or Extracted DNA 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CFB gene", "Complement Factor B gene sequence"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any recent blood transfusions (within 4 weeks)"]
Indications
["Patients with unexplained TMA", "Patients with suspected atypical HUS", "Patients with a family history of aHUS", "Differential diagnosis from other TMAs (STEC-HUS, TTP)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101078-3 ICD-10: D59.3
Clinical summary
This test identifies pathogenic variants within the CFB gene, a key factor in the development of atypical Hemolytic Uremic Syndrome (aHUS). It provides a definitive molecular diagnosis for guiding treatment and risk assessment.
TEST-2781
CFC1 Gene Heterotaxy, Visceral Type 2 Genetic Test

This test evaluates the CFC1 gene for pathogenic variants associated with Heterotaxy, visceral type 2 (HTX2).

Whole Blood or FTA Card 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CFC1 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any relevant family history"]
Indications
["Suspected Heterotaxy, visceral type 2", "Family history of HTX2", "Carrier testing", "Reproductive planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48000-4 ICD-10: Q89.8
Clinical summary
This test evaluates the CFC1 gene for pathogenic variants associated with Heterotaxy, visceral type 2 (HTX2).
TEST-3777
CFHR1 Gene Hemolytic Uremic Syndrome Genetic Test

This test evaluates the CFHR1 gene for pathogenic variants associated with atypical hemolytic uremic syndrome (aHUS). It identifies deletions, duplications, and point mutations wit...

Whole blood, buccal swab, or dried blood spot (FTA card) 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CFHR1 gene variants (deletions, duplications, point mutations)", "Copy Number Variations (CNV) in the CFHR1 gene"]
Parameters
[{"name": "CFHR1 Gene Analysis", "reference_range": "Negative for pathogenic variants"}]
Preparation
["No fasting required.", "No medication changes required."]
Indications
["Diagnosis of atypical hemolytic uremic syndrome (aHUS)", "Familial risk stratification for aHUS", "Personalised treatment planning for aHUS", "Cascade screening for at-risk relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81261-2 ICD-10: D59.3
Clinical summary
This test evaluates the CFHR1 gene for pathogenic variants associated with atypical hemolytic uremic syndrome (aHUS). It identifies deletions, duplications, and point mutations within the gene.
TEST-3815
CFHR2 Gene Hemolytic Uremic Syndrome (HUS) Genetic Test

This test identifies pathogenic mutations in the CFHR2 gene associated with atypical hemolytic uremic syndrome (aHUS). It uses next-generation sequencing to detect various genetic...

Whole blood (EDTA tube), extracted DNA, FTA card blood spot 3 โ€“ 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the CFHR2 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "No specific medication or diet restrictions"]
Indications
["Diagnosis of atypical hemolytic uremic syndrome (aHUS)", "Familial risk stratification for aHUS", "Personalised therapeutic decisions", "Eculizumab eligibility assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94293-7 ICD-10: D59.32, D59.3
Clinical summary
This test identifies pathogenic mutations in the CFHR2 gene associated with atypical hemolytic uremic syndrome (aHUS). It uses next-generation sequencing to detect various genetic alterations.
TEST-3773
CFHR3 Gene Hemolytic Uremic Syndrome Genetic Test

This test evaluates the CFHR3 gene for mutations associated with atypical Hemolytic Uremic Syndrome (aHUS). It identifies pathogenic variants that disrupt complement regulation, le...

Peripheral Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA card) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CFHR3 gene sequence", "Pathogenic variants in CFHR3 gene"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counselling session", "No specific fasting or medication restrictions mentioned"]
Indications
["Suspected atypical Hemolytic Uremic Syndrome (aHUS)", "Family history of aHUS", "Need for genetic confirmation before initiating eculizumab therapy", "Family counseling and screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81439-3 ICD-10: D59.3
Clinical summary
This test evaluates the CFHR3 gene for mutations associated with atypical Hemolytic Uremic Syndrome (aHUS). It identifies pathogenic variants that disrupt complement regulation, leading to the disease.
TEST-3810
CFHR4 Gene Hemolytic Uremic Syndrome (HUS) Genetic Test

This test evaluates the CFHR4 gene for pathogenic variants associated with atypical hemolytic uremic syndrome (aHUS).

Whole blood, extracted DNA, or FTA card 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CFHR4 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Diagnosis of atypical hemolytic uremic syndrome (aHUS)", "Family screening for CFHR4 variants", "Evaluation of patients with suspected complement-mediated disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81329-5 ICD-10: D59.32
Clinical summary
This test evaluates the CFHR4 gene for pathogenic variants associated with atypical hemolytic uremic syndrome (aHUS).

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area